Dr Georgios Giamas

Post:Reader in Cell Signalling (Biochemistry)
Location:JMS BUILDING 3C12

Telephone numbers
UK:01273 873163
International:+44 1273 873163

Research expertise:
download vCarddownload vCard to your mobile


Dr Georgios Giamas obtained his Biology degree (BSc) at the National and Kapodistrian University of Athens in Greece. He then undertook his Doctoral degree (PhD - Magna Cum Laude) at the University of Ulm (Germany). Following 9 months of postdoctoral work at the University of Ulm, he moved  to Imperial College London at 2007, working as a Research Associate till 2010. In 2011 he was awarded Imperial College’s prestigious Junior Research Fellowship. In 2012 he was awarded a NIHR Senior Research Fellowship and was appointed as a Research Team Leader in the Division of Cancer. Since July 2015, he is a Reader in Cell Signalling at University of Sussex and holds an honorary contract (Visiting Reader) with Imperial College.

Dr Giamas is an Associate Fellow of the Higher Education Academy and is the Designated Individual (DI) under the Human Tissue Act in the School of Life Sciences.


Reader in Cell Signalling


Editorial boards and Peer reviewing

  • Deputy Editor in Oncogene (Nature/Springer).
  • Member of the Editorial Board of: Scientific Reports and Breast Cancer Management Journals.
  • Peer Reviewer for scientific journals including: Annals of Oncology, Molecular Cancer Therapeutics, British Journal of Cancer, Pharmacogenomics journal, International Journal of Cancer, BMC Cell Biology, Breast Cancer, Pharmacological Research, Expert Opinion on Drug Discovery, Medicinal Research Reviews, Plos One, Advances in Breast Cancer and others.
  • Peer Reviewer for research grants applications from Medical Research Council (MRC), Breast Cancer Campaign (BCC), Yorkshire Cancer Research and others.


Member  of Professional Bodies

  • ASCO (American Association for Clinical Oncology
  • Association of Union for International Cancer Control (UICC)
  • American Association for Cancer Research (AACR)
  • The European Association for Cancer Research (EACR)